LONG-TERM EX VIVO HAEMATOPOIETIC STEM CELL (HSC) EXPANSION USING BONE-DERIVED REINVIGORATING MESENCHYMAL STEM CELLS (RMSCS).

EHA Library, Sonia Fernández Torices, 419497

CD21 CHIMERIC ANTIGEN RECEPTOR (CAR)-T CELLS FOR CHRONIC LYMPHOCYTIC LEUKAEMIA (CLL)

EHA Library, Nicola Maciocia, 419498

THE CD19-CAR COSTIMULATORY DOMAINS DIFFERENTLY AFFECT RESISTANCE DEVELOPMENT IN B-ALL AND B-CELL LYMPHOMA.

EHA Library, Marta Krawczyk, 419499

PRE-CLINICAL DEVELOPMENT OF AZD5492, A CD8-GUIDED T CELL ENGAGER, FOR B-NON HODGKIN LYMPHOMA INDICATIONS

EHA Library, Corinne Cayatte, 419500

GENETIC POLYMORPHISMS AND CLINICAL PARAMETERS ASSOCIATED WITH METHOTREXATE TOXICITY IN THAI ADULT PATIENTS WITH HEMATOLOGIC MALIGNANCY RECEIVING HIGH-DOSE METHOTREXATE-CONTAINING REGIMENS

EHA Library, Palada Pitakkitnukun, 419501

DRESSING UP T CELLS WITH A PECULIAR TCR TARGETING CATHEPSIN G PEPTIDES ON TWO DIFFERENT HLA MOLECULES LEADS TO THE COMPLETE ERADICATION OF ACUTE MYELOID LEUKEMIA BLASTS IN VIVO

EHA Library, Francesca Marzuttini, 419502

PRECLINICAL DEVELOPMENT OF A CARLY3, A NEW CAR-T TREATMENT BASED ON CD79B FOR PATIENTS WITH NON-HODGKIN LYMPHOMA

EHA Library, Beatriz Martín-Antonio, 419503

AN ALLOGENIC, NON-VIRAL, DOUBLE SITE KNOCK-IN CAR-T TARGETING CD19 AND BCMA

EHA Library, Lianjun Shen, 419504

DEVELOPMENT OF ANTI-CD21 CHIMERIC ANTIGEN RECEPTOR T CELLS FOR T CELL ACUTE LYMPHOBLASTIC LEUKEMIA – CAR ENGINEERING FOR TARGETING A COMPLEX ANTIGEN.

EHA Library, Nicola Maciocia, 419505

CAR T-CELL THERAPY TARGETING CD84 ALONE OR IN COMBINATION WITH CD19 FOR THE TREATMENT OF B-CELL MALIGNANCIES

EHA Library, Ane Altuna, 419506

CAR T CELLS RESIDE IN THE BONE MARROW AND INHIBIT HEMATOPOIESIS

EHA Library, Camille Bigenwald, 419507

LONGITUDINAL SINGLE CELL MULTIOMIC ANALYSIS ALLOW THE IDENTIFICATION OF MECHANISM OF PERSISTENCE AND RESISTANCE TO CAR-T CELLS IN MM

EHA Library, Ana ALFONSO PIEROLA, 419508

WU-NK-101 IS AN OFF-THE-SHELF MEMORY NK CELL WITH A TME-RESILIENT, ANTI-TUMOR PHENOTYPE THAT CAN BE DETECTED IN R/R AML PATIENT PBMC AFTER INFUSION

EHA Library, Sergio Rutella, 419509

THE DIVERSITY AND COMPOSITION OF THE T CELL REARRANGEMENT REPERTOIRE IS ASSOCIATED WITH PROGNOSIS IN MULTIPLE MYELOMA PATIENTS TREATED WITH CAR-T CELL THERAPIES

EHA Library, Alejandro Medina-Herrera, 419510

A NOVEL NANOPARTICLE-BASED IMMUNOTHERAPY FOR ITTP. AUTOANTIGEN-LOADED LIPOSOMES TO RESTORE SELF-TOLERANCE

EHA Library, Daniela Greco, 419511

REAL-WORLD MANUFACTURING EXPERIENCE OF AXICABTAGENE CILOLEUCEL FOR PATIENTS WITH RELAPSED OR REFRACTORY LARGE B-CELL LYMPHOMA TREATED IN SECOND LINE VERSUS THIRD LINE OF THERAPY AND BEYOND

EHA Library, Jason Westin, 419512

CORRELATIONS BETWEEN (CAR) T-CELL METABOLIC AND PHENOTYPICAL STATE AND CLINICAL OUTCOME OF CAR T-CELL THERAPY FOR LARGE B-CELL LYMPHOMA

EHA Library, Arnon P. Kater, 419513

ACQUISITION OF AN IMMUNOSUPPRESSIVE MICROENVIRONMENT AFTER CD19 CAR T CELL TREATMENT IN B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA

EHA Library, Marianna Ponzo, 419514

STAT5 IS ESSENTIAL FOR INDUCING THE SUPPRESSIVE SUBSET AND ATTENUATE CYTOTOXICITY OF VΔ2+ T CELLS IN ACUTE MYELOID LEUKEMIA

EHA Library, cong cheng, 419515

SENESCENCE AND INFLAMMATION ARE ADVERSE UNCHARTED BARRIERS TO EFFICIENT CRISPR-CAS9 GENE-EDITING IN HEMATOPOIETIC STEM CELLS

EHA Library, Anastasia Conti, 419516

DIFFERENTIAL EXPRESSION OF COMPLEMENT-INTERFERON LOOP BEFORE CART THERAPY IN PATIENTS THAT DEVELOP CYTOKINE RELEASE SYNDROME

EHA Library, Maria georgia Koutra, 419517

TRANSCRIPTOMIC SIGNATURES IN T-CELLS COULD HELP TO PREDICT RESPONSE TO CAR T-CELLS IN PATIENTS WITH AGGRESSIVE B CELL LYMPHOMA

EHA Library, Ismael De La Iglesia San Sebastián, 419518

SUSTAINED CORRECTION OF HEREDITARY ANTITHROMBIN DEFICIENCY IN MICE BY AAV8-MEDIATEDGENE DELIVERY

EHA Library, Yanyi Tao, 419519

ADI-270: AN ARMORED ALLOGENEIC ANTI-CD70 CAR GAMMA-DELTA T CELL THERAPY DESIGNED FOR MULTIPLE SOLID AND HEMATOLOGICAL CANCER INDICATIONS

EHA Library, Yvan Chanthery, 419520

SPECIFIC AND PERSONALISED TARGETING OF ANTI-ADAMTS13 AUTOREACTIVE B CELLS IN IMMUNE-MEDIATED TTP USING SWITCHABLE REVCAR T CELLS.

EHA Library, Rutuja Gupte, 419521

PREVALENCE, ETIOLOGY, AND OUTCOME OF DELAYS BETWEEN INITIATION OF LYMPHODEPLETING CHEMOTHERAPY AND CAR T CELL INFUSION

EHA Library, Yannis Valtis, 419522

CIRCULATING T LYMPHOCYTE SUBSETS ON DAY +7 AFTER VARNIMCABTAGENE AUTOLEUCEL (ARI-0001) IN B-CELL NON-HODGKIN LYMPHOMA ARE ABLE TO PREDICT EFFICACY AND TOXICITY

EHA Library, Andrea Rivero Arango, 419523

LONG TERM SURVIVAL IN AML PATIENTS AFTER IMMUNOTHERAPY WITH VIDIDENCEL CORRELATES WITH FUNCTIONAL T AND B-CELL RESPONSES

EHA Library, Arjan van de Loosdrecht, 419524

INATICABTAGENE AUTOLEUCEL(CNCT19) IN RELAPSED OR REFRACTORY B-CELL LYMPHOMA: RESULTS OF A PHASE I CLINICAL TRIAL

EHA Library, Wei Liu, 419525

DENDRITIC CELL-BASED VACCINES (KSD-101) AGAINST EBV-ASSOCIATED HEMATOLOGIC NEOPLASMS: RESULTS FROM AN ONGOING PHASE I CLINICAL STUDY

EHA Library, chunrui li, 419526

IMPLICATIONS OF CAR T CELL REFERRAL AND APHERESIS DELAYS ON OUTCOMES AND TOXICITY IN LYMPHOMA PATIENTS

EHA Library, Alexander P. Boardman, 419527

IMMUNE RECONSTITUTION FOLLOWING CD19 CAR-T FOR R/R B-NHL IS ASSOCIATED WITH IMPROVED SURVIVAL OUTCOMES AND IS IMPAIRED AT TIME OF POST-CAR-T PROGRESSION

EHA Library, Sophia Stock, 419528

IMMUNOGENETIC PROFILING OF EX VIVO GENERATED PATHOGEN-SPECIFIC T CELLS FOR IMMUNOTHERAPY OF OPPORTUNISTIC INFECTIONS POST ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION

EHA Library, Chrysa Pantazi, 419529

SECONDARY MYELOID MALIGNANCIES FOLLOWING CAR T-CELL THERAPY FOR B-CELL MALIGNANCIES: A RETROSPECTIVE ANALYSIS

EHA Library, Amaris Balitsky, 419530

FREQUENCY OF CAR-T CELL MANUFACTURING FAILURES AND OUT-OF-SPECIFICATION PRODUCTS IN THE REAL-WORLD SETTING: A SURVEY FROM THE EBMT CELLULAR THERAPY AND IMMUNOBIOLOGY WORKING PARTY (CTIWP)

EHA Library, Nina Worel, 419532

CAR-HEMATOTOX SCORE PREDICTS OVERALL SURVIVAL IN LARGE B-CELL LYMPHOMAS TREATED WITH ANTI-CD19 CAR T-CELLS: A SUBGROUP ANALYSIS OF CART-SIE

EHA Library, Federico Stella, 419533

POINT-OF-CARE NON-VIRAL PRODUCTION OF CD19 CHIMERIC ANTIGEN RECEPTOR-T CELLS WITH ENHANCED TSCM IMMUNOPHENOTYPE FOR THERAPY OF REFRACTORY B-CELL MALIGNANCIES- PRELIMINARY RESULTS OF PHASE I CLINICAL TRIAL

EHA Library, Pavel Otáhal, 419534

LONG TERM FOLLOW-UP RESULTS OF BRL-201 PHASE I STUDY, A CRISPR-BASED NON-VIRAL PD-1 LOCUS SPECIFIC INTEGRATED ANTI-CD19 CAR-T CELLS IN TREATING RELAPSED OR REFRACTORY NON-HODGKIN'S LYMPHOMA

EHA Library, Biao Zheng, 419535

CAR T TREATMENT ACCESS AND OUTCOMES IN PATIENTS WITH LARGE B-CELL LYMPHOMA ACCORDING TO ETHNICITY AND SOCIOECONOMIC DEPRIVATION IN THE UK

EHA Library, Oana Diana Dragoi, 419536

CHANGING THE NATURAL HISTORY OF PYRUVATE KINASE DEFICIENCY WITH LENTIVIRAL-MEDIATED GENE THERAPY: RESULTS OF A GLOBAL PHASE 1 STUDY

EHA Library, Julian Sevilla, 419537

EARLY AND LATE INTRODUCTION OF CAR T-CELL THERAPY IN LARGE B-CELL LYMPHOMA HAVE COMPARABLE TOXICITY AND EFFICACY OUTCOMES

EHA Library, Magdalena Corona de Lapuerta, 419538

TWO-YEAR FOLLOW-UP RESULTS OF C-CAR066, A NOVEL ANTI-CD20 CHIMERIC ANTIGEN RECEPTOR T-CELL THERAPY IN RELAPSED OR REFRACTORY LARGE B-CELL LYMPHOMA PATIENTS AFTER FAILURE OF CD19 CAR-T THERAPY

EHA Library, Dehui Zou, 419539

FIRST RESULTS OF A COMPREHENSIVE PROSPECTIVE PROTOCOL OF RADIOTHERAPY BRIDGING AND CONSOLIDATION FOR CAR T IN LARGE B-CELL LYMPHOMA (RESTART)

EHA Library, Christianne Bourlon, 419541

CLINICAL OUTCOMES OF PATIENTS WITH RELAPSED/REFRACTORY FOLLICULAR LYMPHOMA TREATED WITH TISAGENLECLEUCEL: PHASE 2 ELARA 3-YEAR FOLLOW-UP

EHA Library, Martin Dreyling, 419542

ASSOCIATION BETWEEN BODY MASS INDEX AND OUTCOMES OF CAR-T THERAPY ACROSS HEMATOLOGIC MALIGNANCIES

EHA Library, Yannis Valtis, 419543

AFTER PROPENSITY SCORE WEIGHTING AXICABTAGENE CILOLEUCEL CONFER SUPERIOR PROGRESSION-FREE SURVIVAL COMPARED TO TISAGENLECLEUCEL IN LARGE B-CELL LYMPHOMAS: FINAL RESULTS OF THE ITALIAN CART-SIE STUDY

EHA Library, Federico Stella, 419544

LONG-TERM DURABLE RESPONSES IN PATIENTS WITH R/R ALL, DLBCL, AND FL TREATED WITH TISAGENLECLEUCEL AND ITS ASSOCIATION WITH PERSISTENCE OF CHIMERIC ANTIGEN RECEPTOR (CAR) T-CELLS

EHA Library, Harald Maier, 419545

FIRST REAL-WORLD EXPERIENCE OF COMMERCIAL RELMACABTAGENE AUTOLEUCEL (RELMA-CEL) FOR RELAPSED/REFRACTORY CENTRAL NERVOUS SYSTEM LYMPHOMA: A MULTICENTER RETROSPECTIVE ANALYSIS OF PATIENTS IN CHINA

EHA Library, Wenyan Yu, 419546

INB-100: PILOT STUDY OF DONOR DERIVED, EX-VIVO EXPANDED/ACTIVATED GAMMA-DELTA T CELL INFUSION FOLLOWING HAPLOIDENTICAL HEMATOPOIETIC STEM-CELL TRANSPLANTATION  AND POST-TRANSPLANT CYCLOPHOSPHAMIDE

EHA Library, Joseph McGuirk, 419547

HIGH EFFICACY AND FAVORABLE SAFETY OF CD20-TARGETED CAR-T THERAPY FOR BTK INHIBITOR-REFRACTORY WALDENSTRÖM MACROGLOBULINEMIA (WM)/ LYMPHOPLASMACYTIC LYMPHOMA (LPL)

EHA Library, Brian Till, 419548

HEMATOPOIETIC STEM CELL GENE THERAPY FOR HURLER SYNDROME: INTERIM SKELETAL, NEUROLOGICAL AND SYSTEMIC OUTCOMES

EHA Library, Maria Ester Bernardo, 419549

CHIMERIC ANTIGEN RECEPTOR T-CELL THERAPY IS FEASIBLE IN PATIENTS 80 YEARS OF AGE OR OLDER WITH B-CELL LYMPHOMA: A US MULTICENTER COLLABORATIVE STUDY

EHA Library, Julio Chavez, 419550

ALLOGENIC STEM CELL TRANSPLANT (SCT) AFTER CAR-T CELL THERAPY FOR RELAPSE OR REFRACTORY B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA (R/R B-ALL) IN PEDIATRIC PATIENTS. A SINGLE CENTER EXPERIENCE

EHA Library, Anna Alonso-Saladrigues, 419553

SINGLE CELL ANALYSIS REVEALS THAT T CELLS AND MONOCYTES CONTRIBUTE TO RESPONSE AND EARLY PROGRESSION RESPECTIVELY IN FOLLICULAR LYMPHOMA PATIENTS TREATED WITH PEMBROLIZUMAB

EHA Library, Zhi-Zhang Yang, 419554

COMPARABLE OUTCOMES OF CD19-TARGETING CAR-T THERAPY IN TRANSFORMED FOLLICULAR LYMPHOMA AND DE NOVO DIFFUSE LARGE B-CELL LYMPHOMA

EHA Library, Alfredo Rivas-Delgado, 419555

DROPLET DIGITAL PCR AND FLOW CYTOMETRY SENSITIVITY FOR MEASURING CAR-T CELL KINETICS IN ADULT PATIENTS WITH RELAPSED/REFRACTORY B CELL ACUTE LYMPHOBLASTIC LEUKEMIA TREATED WITH OBECABTAGENE AUTOLEUCEL

EHA Library, Claire Roddie, 419556

EXPLORING PATIENT CHARACTERISTICS AND CLONAL EVOLUTION IN POST CAR-T MYELOID NEOPLASMS

EHA Library, Francesca Sillito, 419557

PHASE I STUDY OF AN ANTI-CD7 UNIVERSAL CAR-T THERAPY FOR PATIENTS WITH RELAPSED/REFRACTORY CD7 POSITIVE T-ALL/LBL

EHA Library, He Huang, 419558

CD7 CAR-T THERAPY FOR PATIENTS WITH T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA AND T-CELL LYMPHOBLASTIC LYMPHOMA WHO RELAPSED AFTER HEMATOPOIETIC STEM CELL TRANSPLANTATION

EHA Library, Xingyu Cao, 419559

CD7.PEBL-CART FOR PATIENTS WITH RELAPSED/REFRACTORY T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA

EHA Library, Marco Becilli, 419560

TARGETING OPPORTUNISTIC INFECTIONS POST ALTERNATIVE-DONOR HEMATOPOIETIC CELL TRANSPLANTATION WITH PATHOGEN-SPECIFIC T CELLS

EHA Library, Anastasia Papadopoulou, 419561

C-CAR039, A NOVEL ANTI-CD20/CD19 BI-SPECIFIC CAR T-CELL THERAPY SHOWS DEEP AND DURABLE CLINICAL BENEFITS IN PATIENTS WITH RELAPSED OR REFRACTORY B-CELL NON-HODGKIN LYMPHOMA IN LONG TERM FOLLOW UP

EHA Library, Aibin Liang, 419562

RENI-CEL, THE FIRST ASCAS12A GENE-EDITED CELL THERAPY, SHOWS PROMISING PRELIMINARY RESULTS IN KEY CLINICAL OUTCOMES IN TRANSFUSION-DEPENDENT BETA-THALASSEMIA PATIENTS TREATED IN THE EDITHAL TRIAL

EHA Library, Haydar Frangoul, 419563

CAR T-CELL THERAPY BRIDGING ALLOGENIC HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR CHILDREN WITH RELAPSED OR REFRACTORY ACUTE MYELOID LEUKEMIA

EHA Library, Zhiyong Peng, 419564

MULTICENTER ANALYSIS OF VOXELOTOR’S IMPACT ON RED BLOOD CELL TRANSFUSIONS IN PATIENTS WITH SICKLE CELL DISEASE:  RESULTS FROM A RETROSPECTIVE, REGISTRY STUDY

EHA Library, Biree Andemariam, 419565

ROBUST AUTOLOGOUS CD34+ HSPC MANUFACTURING WITH A CLOSED AND AUTOMATED PROCESS OPTIMIZED FOR PATIENTS WITH SICKLE CELL DISEASE

EHA Library, Paul Kopesky, 419566

A NOVEL ALLOSTERIC ACTIVATOR OF PYRUVATE KINASE ENHANCES HUMAN AND MOUSE ENZYMATIC ACTIVITY AND LEADS TO HEMATOLOGICAL IMPROVEMENTS IN SICKLE CELL DISEASE MOUSE MODELS

EHA Library, Mira Pochron, 419567

GMI-1687-101, A PHASE 1A FIRST IN HUMAN TRIAL OF SECOND-GENERATION E-SELECTIN ANTAGONIST GMI-1687

EHA Library, Jay Lozier, 419568

FACTORS DRIVING PARTICIPATION IN CLINICAL TRIALS AMONG PEOPLE WITH SICKLE CELL DISEASE DIFFER IN IMPORTANCE ACROSS GEOGRAPHIC REGIONS: FINDINGS FROM THE GLOBAL LISTEN SURVEY

EHA Library, Raffaella Colombatti, 419569

ADHERENCE, TREATMENT USE, AND CLINICAL OUTCOMES IN PATIENTS WITH SICKLE CELL DISEASE WITH RECURRENT VASO-OCCLUSIVE CRISES TREATED WITH L-GLUTAMINE, VOXELOTOR, OR CRIZANLIZUMAB IN THE UNITED STATES

EHA Library, Chuka Udeze, 419570

THE EFFECT OF RED BLOOD CELL EXCHANGE ON ECHOCARDIOGRAPHIC FINDINGS IN SCD

EHA Library, Jules M.Ross, 419571

CHANGES IN PHYSICAL, MENTAL, AND SOCIAL HEALTH OF ADULTS WITH SICKLE CELL DISEASE FOLLOWING ALLOGENEIC STEM CELL TRANSPLANTATION: A MIXED-METHODS, PROSPECTIVE COHORT STUDY

EHA Library, Elisabeth Dovern, 419572

HYDROXYUREA MODULATES VLA-4 BINDING TO VCAM-1 THROUGH ERYTHROID SIGNALING PATHWAYS INDEPENDENT OF ADHESION RECEPTOR EXPRESSION IN PRIMARY CULTURES OF SICKLE ERYTHROBLASTS

EHA Library, Moira Lancelot, 419573

REAL-WORLD IMPLEMENTATION OF THE DAVID-CAROLL BUPRENORPHINE PROTOCOL FOR PAIN MANAGEMENT IN SICKLE CELL DISEASE

EHA Library, Najibah Galadanci, 419574

PHASE 1 STUDY OF SAFETY AND PHARMACOKINETICS OF CSL889 (HEMOPEXIN) IN ADULTS WITH SCD

EHA Library, Bart Biemond, 419576

ENHANCING SICKLE CELL CRISIS MANAGEMENT IN THE EMERGENCY DEPARTMENT: A MIXED-METHODS QUALITY IMPROVEMENT PROJECT

EHA Library, James Cai, 419577

IMPACT OF HYDROXYUREA ON CEREBRAL VASCULOPATHY IN CHILDREN WITH SICKLE CELL ANEMIA AFTER INITIATION FOR FREQUENT CRISES OR SEVERE ANEMIA IN ABSENCE OF ABNORMAL VELOCITIES AND ARTERIAL STENOSIS

EHA Library, Françoise Bernaudin, 419578

SURVIVAL RATES OF A COHORT OF ADULTS WITH SICKLE CELL DISEASE BY BASELINE HEMOGLOBIN VALUES OVER A 10-YEAR FOLLOW-UP PERIOD

EHA Library, Pablo Bartolucci, 419579

HEALTH-RELATED QUALITY OF LIFE IMPROVEMENTS AFTER EXAGAMGLOGENE AUTOTEMCEL IN PATIENTS WITH SEVERE SICKLE CELL DISEASE

EHA Library, Haydar Frangoul, 419580

THE ROLE OF INDUCIBLE NITRIC OXIDE SYNTHASE IN HYDROXYUREA IMPAIRMENT OF ANGIOGENESIS

EHA Library, Teodora Dragojević, 419581

PHYSICIANS’ PERCEPTIONS OF BARRIERS TO PRESCRIBING SICKLE CELL DISEASE TREATMENTS IN THE UNITED STATES

EHA Library, Aine Kyle, 419582

LONG-TERM EFFECT OF VOXELOTOR ON RED BLOOD CELL TRANSFUSIONS AND VASO-OCCLUSIVE CRISES IN PATIENTS WITH SICKLE CELL DISEASE:  RESULTS FROM AN OPEN-LABEL EXTENSION OF THE PHASE 3 HOPE TRIAL

EHA Library, Richard Drachtman, 419583

HEME-INDUCED NEUTROPHIL GASDERMIN-D ACTIVATION IS SUPPRESSED BY INTERLEUKIN-27 IN SICKLE CELL DISEASE

EHA Library, Adekunle Alagbe, 419584

VACUOLES OF RED CELLS IN ASPLENIA: MERE REMAINS OR ENCHANTED APPARITIONS (OR BOTH)?

EHA Library, Lucie Dumas, 419585

EFFECT OF VOXELOTOR ON CEREBRAL PERFUSION AND CEREBRAL OXYGENATION IN ADULT PATIENTS WITH SICKLE CELL DISEASE; 12 MONTH FOLLOW UP

EHA Library, Kadère Konté, 419586

HEALTH-RELATED QUALITY OF LIFE IN PEOPLE LIVING WITH SICKLE CELL DISEASE IN EUROPE: A SYSTEMATIC LITERATURE REVIEW

EHA Library, Giovanna Barcelos, 419587

CRYOPRESERVATION OF SICKLE RED BLOOD CELLS FOR COMPARISON OF OXYGENSCAN PARAMETERS BETWEEN LABORATORIES TO ENABLE DATA HARMONIZATION

EHA Library, Marissa Traets, 419588

EVALUATION OF LIVER IRON CONCENTRATION IN PATIENTS WITH SICKLE CELL DISEASE USING AUTOMATED DEEP-LEARNING ASSISTED ANALYSIS OF MAGNETIC RESONANCE IMAGES

EHA Library, Adlette Inati, 419589

RISK FACTORS FOR MULTIPLE ORGAN DAMAGES IN A COHORT OF INDIAN SICKLE CELL DISEASE PATIENTS

EHA Library, Nikhil Shinde, 419590

FACTORS LIMITING HYDROXYCARBAMIDE DOSING IN ADULTS WITH SCD. RESULTS FROM THE UK’S SICKLE NATURAL HISTORY STUDY

EHA Library, Michael Neale, 419591

DECIPHERING THE DIFFERENT MODELS OF VASO-OCCLUSIVE EVENTS: FIRST STEPS TOWARDS A PERSONALIZED APPROACH TO THE TREATMENT OF PAINFUL VASO-OCCLUSIVE CRISIS

EHA Library, Berengere Koehl, 419592

MORTALITY AND CLINICAL COMPLICATIONS AMONG PATIENTS WITH SICKLE CELL DISEASE WITH RECURRENT VOCS IN CANADA

EHA Library, Lauren Lilly, 419593

TREATMENT UTILIZATION AND CLINICAL COMPLICATIONS IN PATIENTS WITH SICKLE CELL DISEASE RECEIVING FREQUENT RED BLOOD CELL TRANSFUSIONS IN THE UNITED STATES

EHA Library, Chuka Udeze, 419594

ALL-CAUSE ANAEMIA TRUMPS DEGREE OF HAEMOLYSIS AS A DETERMINANT OF QUALITY OF LIFE: THE UK MULTI-SITE SICKLE NATURAL HISTORY STUDY

EHA Library, Jumoke Stella Okikiolu, 419595

CO-INHERITANCE OF Α-THALASSEMIA IN HBSC DISEASE CORRELATES WITH INCREASED RED BLOOD CELL DEHYDRATION AND REDUCED CLINICAL COMPLICATIONS

EHA Library, Marissa Traets, 419596

INVESTIGATING INEFFECTIVE ERYTHROPOIESIS IN A PAEDIATRIC SICKLE CELL DISEASE COHORT

EHA Library, Margherita Di Mauro, 419597

REAL-WORLD ASSESSMENT AND CLINICAL VALIDATION OF RED BLOOD CELL (RBC) HEALTH BIOMARKERS IN SICKLE CELL DISEASE (SCD)

EHA Library, Jennell White, 419598

MAPPING THE PRODROMAL STAGE OF VASO-OCCLUSIVE CRISES: A PATIENT EXPERIENCE AND WEARABLE BIOMETRICS-DRIVEN APPROACH

EHA Library, Kim Summers, 419599

THE EARLY MYELOID COMMITMENT OF HSPCS IN SICKLE CELL ANEMIA IS ASSOCIATED WITH ABERRANT DIFFERENTIATION TO THE MONOCYTIC LINEAGE

EHA Library, Berengere Koehl, 419600

EFFICACY AND SAFETY OF BRL-101, CRISPR-CAS9-MEDIATED GENE EDITING OF THE BCL11A ENHANCER IN TRANSFUSION-DEPENDENT ΒETA-THALASSEMIA

EHA Library, Biao Zheng, 419601